Russian Vaccine Approved in Hungary, EU Authorization Has Yet to Begin
Hungarian authorities have completed the final steps of authorizing the emergency use of the Gamaleya Research Institute’s Russian vaccine. While Hungary no longer faces any obstacles in using Sputnik V, the rest of the European Union needs to wait until the European Medicines Agency authorizes its use, a process which has not yet begun.
Minister of Human Resources Miklós Kásler posted on his Facebook page saying that the National Public Health Center (NNK) has licensed the use of the Russian Sputnik V vaccine. Kásler said “from a medicinal efficacy perspective, the vaccine meets the specifications of the producer, and from an immunobiological perspective, it is usable on humans.”